Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Absonutrix, LLC
WARNING LETTER
•Absonutrix, LLC•May 31, 2017

Absonutrix, LLC – FDA Warning Letter, May 31, 2017

Record Details

The FDA issued a Warning Letter to Absonutrix following a May 2017 review of their website, www.absonutrix.com. The agency determined that numerous products, including Absonutrix Forskolin Pure X-treme Capsules, Absonutrix Fucoidan Max Strength, and Absonutrix Parasite Detox X-Treme, are illegally marketed as unapproved new drugs. Website claims, such as "aids in the inhibition of colon cancer cell growth" and "help fight the growth of tumors," establish these products as intended for the cure, mitigation, treatment, or prevention of disease, or to affect body structure/function, classifying them as drugs under 21 U.S.C. 321(g)(1)(B) and (C). Since these products are not generally recognized as safe and effective for their intended uses, they are "new drugs" under 21 U.S.C. 321(p) and cannot be introduced into interstate commerce without prior FDA approval, violating 21 U.S.C. 331(d) and 355(a). Furthermore, specific products like Absonutrix Forskolin Pure X-treme Capsules and Absonutrix Lavender Oil X-Treme are misbranded under 21 U.S.C. 352(f)(1) because they lack adequate directions for use, as they are intended for diseases requiring professional supervision. The introduction of these misbranded drugs violates 21 U.S.C. 331(a). The letter also cited the firm for improperly displaying the FDA logo on its website, which implies endorsement. Absonutrix must take prompt action to correct all violations and respond in writing within 15 working days, outlining corrective steps, timelines, and supporting documentation, to avoid potential legal action such as seizure or injunction.

Company
Absonutrix, LLC
Inspection date
May 31, 2017
Product type
Drugs
Office
Atlanta District Office
Person
  • Ingrid A. Zambrana
View Company Profile

ID · 53f1c59b-d92f-49a9-b8f1-787b09fe3a9b

Violation Codes9
21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 353(b)(1)(A)21 CFR 201.5

Full citation text and observation details available on the Dashboard.

Other documents for Absonutrix, LLC
  • WARNING_LETTER - 2019-03-22March 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Absonutrix, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.